Optimized testing to diagnose complex conditions
Accurate and dependable endocrine function testing is one of the cornerstones of the Mayo Clinic practice. Our test menu is designed to address the complex mechanisms of endocrine disorders and includes testing for adrenal disorders, thyroid disorders, development and growth disorders, and more. Through continuous laboratory innovation based on clinical collaboration, our experts are optimizing methodologies and reference ranges to enable the most precise results.
“Our collaborative care model is very important. When we develop a new test or technique, we rely on our clinicians to help us validate it. Without that collaboration, it is very difficult to develop precise testing.”
Ravinder Singh, Ph.D., professor of laboratory medicine and pathology in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition
OUR DIFFERENCE
News and updates
The latest
Working together, Mayo Clinic laboratory medicine specialists and clinicians helped Elyn Simmons get her life back — and welcome two new lives to the world.
Mayo Clinic Laboratories’ newly expanded Hereditary Pancreatitis Gene Panel is transforming how clinicians diagnose and manage a complex, often elusive disease. Developed through close collaboration between lab scientists, genetic counselors, and clinicians, the test uses a whole exome sequencing backbone to analyze nine carefully selected genes with strong clinical relevance. This focused approach avoids ambiguous results while empowering early diagnosis, cancer risk assessment, and family testing. Built on a whole exome backbone with reflex capabilities, the panel represents a major step forward in precision medicine — offering clarity for patients and providers, and a platform for future genomic innovation.
In this “Hot Topic,” Joshua Bornhorst, Ph.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, reviews biomarker component testing for hepatocellular carcinoma, explains the GALAD score, and explores GALAD score testing at Mayo Clinic Laboratories.
Understanding the difference between benign and malignant adrenal tumors has always been difficult, but the new Urinary Steroid Profile assay will assist with this medical challenge.
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.